Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jennifer S. Orozco"'
Autor:
Amber C. King, Eli L. Diamond, Jennifer S. Orozco, Hannah R. Morse, Linda L. Ouyang, Heiko Schöder, Raajit K. Rampal
Publikováno v:
Clinical Case Reports, Vol 7, Iss 10, Pp 1989-1993 (2019)
Abstract Our rechallenge of cobimetinib in an Erdheim‐Chester Disease (ECD) patient for the rare adverse effect, “dropped head syndrome,” with a previously unexplored cobimetinib regimen was successful. Similar to other experiences with targete
Externí odkaz:
https://doaj.org/article/9e1e6f10b4fd4244b1452a2eef66da91
Autor:
Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Sydney Lu, Dhwani Patel, Tim J Peterson, Neha Korde, Carlyn Tan, Katrina M Piedra, Urvi A Shah, Alexander M. Lesokhin, Jennifer S. Orozco, Andriy Derkach, Cy Wilkins
Publikováno v:
Br J Haematol
Incidence of venous thromboembolism (VTE) varies across different regimens in newly diagnosed multiple myeloma (NDMM) patients. Limited data exist on the use of direct oral anticoagulants as thromboprophylaxis in the setting of haematologic malignanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f97ba277ff5b04d9bed5725906da312a
https://doi.org/10.1111/bjh.17772
https://doi.org/10.1111/bjh.17772
Autor:
Meera Mohan, Melody Renee Becnel, Urvi A. Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S. Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal, Sharmilan Thanendrarajan, Sabarinath Venniyil Radhakrishnan, Samer Al Hadidi, Carlyn Tan, Sham Mailankody, Malin Hultcrantz, Neha Korde, Hani Hassoun, Alexander M. Lesokhin, Sheeba K. Thomas, Krina K. Patel, Elisabet E. Manasanch, Donna M. Weber, Aniko Szabo, Gregory P. Kaufman, Hans C. Lee, Maurizio Zangari, Frits van Rhee, Saad Z. Usmani, Anita D'Souza, Robert Z. Orlowski, Carolina Schinke
Publikováno v:
American journal of hematologyREFERENCES. 97(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0b61dead7e831b8d4988f50d53d3a3
https://pubmed.ncbi.nlm.nih.gov/35472167
https://pubmed.ncbi.nlm.nih.gov/35472167
Autor:
Krisoula Spatz, Prakirthi Yerram, Lauren DeRespiris, Richard F Tizon, Terry K. Pak, Andréa LeVoir, Scott Freeswick, Samantha N Reiss, Lisa Modelevsky, Josiah D. Land, Sherry Mathew, Carmen Lau, Shirley Qiong Yan, Lauren Koranteng, Phuong H. Dao, Kate E Reichert, Jennifer Thackray, Nicole P Daukshus, Jennifer S. Orozco, Stephen Harnicar, Larry W Buie, Manpreet K. Boparai, Michael J Buege, Dazhi Liu
Publikováno v:
J Oncol Pharm Pract
PurposeWith the rapid spread of COVID-19 in New York City since early March 2020, innovative measures were needed for clinical pharmacy specialists to provide direct clinical care safely to cancer patients. Allocating the workforce was necessary to m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2232d99ac821194bf5e6eebc3d4856
https://pubmed.ncbi.nlm.nih.gov/33459159
https://pubmed.ncbi.nlm.nih.gov/33459159
Publikováno v:
Ann Pharmacother
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of selinexor for management of relapsed multiple myeloma (MM). Data Sources: A literature search was performed of PubMed and MEDLINE databases (January 1, 2000, to November
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841e64bc3fc549c41a7a2d774dcd9eff
https://europepmc.org/articles/PMC8498942/
https://europepmc.org/articles/PMC8498942/
Autor:
Jennifer S. Orozco, Amber C. King
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy in relapsed and refractory diffuse large B-cell lymphoma (DLBCL) patients who have had suboptimal responses to conventional therapies. The immune acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a9edf3dd149b24628decacb0a9678a
https://doi.org/10.6004/jadpro.2019.10.8.9
https://doi.org/10.6004/jadpro.2019.10.8.9
Autor:
Hani Hassoun, Sergio Giralt, Ola Landgren, Gunjan L. Shah, Urvi A Shah, Malin Hultcrantz, Michael Scordo, Andriy Derkach, Oscar B Lahoud, Sham Mailankody, Neha Korde, Heather Landau, Carlyn Tan, Tim J Peterson, Sydney X. Lu, David J. Chung, Alexander M. Lesokhin, Jennifer S. Orozco, Kylee H Maclachlan, Dhwani Patel
Publikováno v:
Blood. 138:1644-1644
Introduction Belantamab mafodotin is an antibody drug conjugate targeting B-cell maturation antigen (BCMA) on plasma cells and was the first BCMA-targeted drug approved by the FDA. Single agent effect was around 31-34% in a recent phase II study (Lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d6722f2e5018c00e1e042a38cd543dd
https://doi.org/10.1182/blood-2021-153443
https://doi.org/10.1182/blood-2021-153443
Autor:
Esperanza B. Papadopoulos, Brian C. Shaffer, Jeremy J. Pappacena, Ann A. Jakubowski, Patrick Hilden, Jennifer S. Orozco, Valkal Bhatt, Molly Maloy, Larry W Buie
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S276-S277
Introduction In patients with poor risk AML or MDS in first complete remission (CR1), alloSCT can be potentially curative. Comparison of the non-hematologic toxicities between total body irradiation (TBI)-based conditioning versus chemotherapy alone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e208814b857a9e65222e5e95304864e7
https://doi.org/10.1016/j.bbmt.2018.12.342
https://doi.org/10.1016/j.bbmt.2018.12.342